CMR Surgical vs EndoQuest Robotics

Side-by-side comparison of AI visibility scores, market position, and capabilities

CMR Surgical logo

CMR Surgical

ChallengerHealthcare

Surgical Robotics

CMR Surgical makes the Versius robotic surgery system used in 30+ countries across 30,000+ procedures; raised $1.43B total; received FDA clearance in Oct 2024; raised $200M in Apr 2025; exploring ~$4B sale.

About

CMR Surgical is a Cambridge, UK-based medical robotics company that developed Versius, a modular, portable robotic surgery system designed to integrate into any standard operating room without requiring dedicated infrastructure. Founded in 2014, CMR Surgical built Versius to be smaller, lighter, and more flexible than established competitors, enabling surgeons to perform minimally invasive laparoscopic procedures — including cholecystectomy, hernia repair, and colorectal surgery — with robotic precision. Versius uses a wristed instrument design that mimics natural hand and wrist movements, providing surgeons enhanced dexterity within confined surgical spaces.

Full profile
EndoQuest Robotics logo

EndoQuest Robotics

EmergingHealthcare

Surgical Robotics

Flexible endoluminal surgical robot for GI procedures. $232M raised (Series D-2, Jul 2025); FDA-approved PARADIGM pivotal trial underway at Mayo Clinic, Cleveland Clinic, and Brigham and Women's.

About

EndoQuest Robotics is developing the Endoluminal Surgical (ELS) System, a flexible robotic platform designed for minimally invasive gastrointestinal surgery performed entirely through natural orifices — without external incisions. The system is engineered for therapeutic endoscopists and colorectal surgeons performing complex upper and lower GI procedures, including endoscopic submucosal dissection (ESD). EndoQuest closed a Series D-2 round in July 2025, co-led by Crescent Enterprises and Dr. Fred Moll (founder of Intuitive Surgical), bringing total funding to $232M. The FDA-authorized PARADIGM pivotal trial is actively enrolling 50 patients at five leading U.S. institutions — including Mayo Clinic, Cleveland Clinic, Brigham and Women''s Hospital, AdventHealth, and HCA Healthcare — with first ESD procedures completed in 2025. The FDA has cleared the final stage of the trial.

Full profile

Key Details

Category
Surgical Robotics
Surgical Robotics
Tier
Challenger
Emerging
Entity Type
brand
brand

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.